FIELD: medicine, dermatology.
SUBSTANCE: invention can be used for treatment of allergic dermatosis. Method involves intramuscular administration of dalargin in the dose 1 ml for 20-25 days intravenous administration of haemodesum in the dose 200.0-400.0 ml, 2 times per a week, 6-7 injections for course. For dermosorption 10% cholestyramine ointment is used in acute inflammatory period and after attenuation of the latter the external treatment with turf "Relikt-05" an aqueous extract is continued up to the complete recovery of the skin process. Invention promotes to the enhanced effectiveness of sorption-correcting therapy of allergic dermatosis based on the effective elimination of immune complexes from surface of damage foci and by effect on all links of etiopathogenesis.
EFFECT: improved and enhanced effectiveness of treatment method.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING VIDAL'S DISEASE | 2008 |
|
RU2396963C1 |
| METHOD OF TREATING PATIENTS WITH PSORIASIS EXUDATIVA | 2009 |
|
RU2412684C2 |
| METHOD OF TREATING PATIENTS WITH PSORIASIS ARTHROPICA | 2011 |
|
RU2479302C1 |
| METHOD FOR TREATING ATYPICAL FORM OF PSORIASIS | 2000 |
|
RU2200594C2 |
| LIPID COMPLEX FOR TREATMENT OF CHRONIC DERMATOSES | 1998 |
|
RU2159118C2 |
| METHOD OF STEPPED THERAPY OF PSORIASIS OF UNDEFINED CLINICAL COURSE | 2008 |
|
RU2398561C1 |
| BIOLOGICALLY-ACTIVE AGENT FOR DERMATOSES TREATMENT | 2008 |
|
RU2407535C2 |
| AGENT FOR COMPLEX THERAPY OF CHRONIC DERMATOSIS, PSORIASIS, ATOPIC DERMATITIS, ECZEMA AND XERODERMIA AND METHOD OF TREATMENT OF CHRONIC DERMATOSIS | 2001 |
|
RU2196585C2 |
| METHOD FOR COMPLEX EXPOSURE ON NEURAL-REFLEX ITCHING MECHANISMS IN PATIENTS WITH ATOPIC DERMATITIS | 2013 |
|
RU2523634C1 |
| METHOD OF TREATMENT OF PSORIATIC PATIENTS | 1996 |
|
RU2149002C1 |
